Trademarkia Logo

Australia

AU$
APDEYA
Cancelled: Cancelled at the request of IB

Last updated on 12 Feb 2025

Owner Info

Alexion Pharmaceuticals, Inc.

121 Seaport Boulevard

Boston MA 02210, UNITED STATES OF AMERICA

Serial Number

2313779 filed on 10 Oct 2022

Correspondent

Dennemeyer & Associates S.A.

55 rue des Bruyères,

L-1274 Howald,

LUXEMBOURG

APDEYA

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of hematological, nephrological, autoimmune, immunological, ocular, neurological and inflammatory relate Read More

Mark Details


Serial Number

2313779

Registered On

10 Oct 2022

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

22 Jul 2022

Mark Type

US

Legal History


Show more

Status DateAction Taken
12th Feb 2025Status change to Voided
9th May 2024Amendment to International Registration Contact Requested
3rd Mar 2023International Registration in Australia Protected correspondence sent
2th Mar 2023IP Right Registration Published
2th Mar 2023Status change to Registered/Protected
23rd Dec 2022Application Accepted correspondence sent
23rd Dec 2022IP Right has been Examined
23rd Dec 2022IP Right Acceptance Published
14th Nov 2022Status change to Accepted
14th Nov 2022Examination expedited